The effect of inhaled corticosteroids on airway mast cells in type 2 low asthma

M. Hvidtfeldt (Copenhagen, Denmark), A. Pulga (Copenhagen, Denmark), A. Sverrild (Copenhagen, Denmark), M. Hostrup (Copenhagen, Denmark), C. Sanden (Lund, Sweden), O. Nielsen (Aarhus, Denmark), D. Bornesund (Lund, Sweden), C. Clausson (Lund, Sweden), J. Erjefält (Lund, Sweden), C. Porsbjerg (Copenhagen, Denmark)

Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Session: Asthma pharmacology: clinical trials and mechanistic insights
Session type: Oral Presentation
Number: 3698
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Hvidtfeldt (Copenhagen, Denmark), A. Pulga (Copenhagen, Denmark), A. Sverrild (Copenhagen, Denmark), M. Hostrup (Copenhagen, Denmark), C. Sanden (Lund, Sweden), O. Nielsen (Aarhus, Denmark), D. Bornesund (Lund, Sweden), C. Clausson (Lund, Sweden), J. Erjefält (Lund, Sweden), C. Porsbjerg (Copenhagen, Denmark). The effect of inhaled corticosteroids on airway mast cells in type 2 low asthma. 3698

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of inhaled corticosteroids on airway hyperresponsiveness to mannitol in patients with Type 2 low asthma
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020


Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2-agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 35s
Year: 2003

Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004

Influence of inhaled corticosteroids on airway epithelial cell mediator release in wheezing children
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008

Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma
Source: Eur Respir J 2002; 20: 1080-1087
Year: 2002



Inhaled corticosteroids and growth of airway function in asthmatic children
Source: Eur Respir J 2004; 23: 861-868
Year: 2004



Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness
Source: Eur Respir J 2006; 27: 1144-1151
Year: 2006



Cancer-protective effects of inhaled corticosteroids in COPD are likely related to modification of epithelial activation
Source: Eur Respir J, 54 (3) 1901088; 10.1183/13993003.01088-2019
Year: 2019



The influence of smoking on the formation of cold airway hyperresponsiveness and destructive-cytolytic profile of goblet cells in asthma patients
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018


Sputum eosinophil counts in a large population of mild-to-moderate asthmatics: distribution, relationship with methacholine bronchial responsiveness and influence of a regular treatment with low doses of inhaled corticosteroids
Source: Eur Respir J 2001; 18: Suppl. 33, 531s
Year: 2001

Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 261s
Year: 2001

The effect of single dose montelukast and desloratadine, alone and in combination, on the allergen induced late airway response in atopic asthma
Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment
Year: 2008



Effects of corticosteroids on airway inflammation in cough variant asthma
Source: Annual Congress 2004 - Understanding airway regulation by airway monitoring
Year: 2004

Effect of oral prednisolone on the bronchoprotective effect of formoterol in patients with persistent asthma
Source: Eur Respir J 2001; 17: 374-379
Year: 2001



High sputum eosinophils are associated with better response to inhaled corticosteroids in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 113s
Year: 2002

Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma
Source: Eur Respir J 2006; 27: 172-187
Year: 2006



Zafirlucast influence on interleukin-2 in children with moderate bronchial asthma after cancellation of inhaled corticosteroids
Source: Eur Respir J 2001; 18: Suppl. 33, 122s
Year: 2001

Evidence of a distinct phenotype of adult onset asthma characterized by an airway neutrophilia and poor response to inhaled corticosteroids
Source: Eur Respir J 2001; 18: Suppl. 33, 21s
Year: 2001

Changes in objective markers following inhaled corticosteroids (ICS) in asthmatics with airway hyperresponsiveness (AHR) to mannitol
Source: International Congress 2019 – Airway physiology
Year: 2019

The importance of early applying inhaled corticosteroids in patients with mild bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 57s
Year: 2002